Skip to main content
Log in

Biodistribution and estimation of radiation-absorbed doses in humans for 13N-ammonia PET

  • Original Article
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Objective

To evaluate the biodistribution of radiation-absorbed doses of 13N-ammonia in healthy people.

Methods

Five healthy human subjects underwent whole-body PET and CT scans after injection of 555–740 MBq of 13N-ammonia. Five serial dynamic emission scans in each healthy volunteer were acquired. Regions of interest were drawn on the CT image and transferred to the corresponding transverse PET slice. Estimates of the radiation-absorbed doses were calculated using the medical internal radiation dosimetry method.

Results

The highest concentrations of 13N-ammonia were found in the heart and liver, followed by pancreas, brain, spleen and stomach. The highest absorbed organ doses were to the heart wall (7.14E−03 ± 3.63E−03 mGy/MBq) and kidneys (6.02E−03 ± 3.53E−03 mGy/MBq). The effective dose (ED) was 6.58E−03 ± 1.23E−03 mSv/MBq.

Conclusions

With these new estimates for 13N-ammonia dosimetry, the results for Chinese people were not appreciably different from those of the previous study performed with old devices. As one of the most important myocardial perfusion PET tracers, the whole-body 13N-ammonia PET appears to be safe for humans, yielding a relatively modest radiation burden that would allow multiple PET studies on the same subject per year.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Clark JC, Aigbirdhio FI. Chemistry of nitrogen-13 and oxygen-15. In: Welch MJ, Redvanly CS, editors. Handbook of Radiopharmaceuticals. Chichester: Wiley; 2003. p. 119–40.

    Google Scholar 

  2. Phelps ME, Hoffman EJ, Raybaud C. Factors which affect cerebral uptake and retention of 13 NH3. Stroke. 1977;8:694–702.

    Article  CAS  PubMed  Google Scholar 

  3. Schelbert HR. PET studies of the heart. In: Phelps ME, Mazziota JC, Schelbert HR, editors. Positron emission tomography and autoradiography. New York: Raven Press; 1986. p. 581–662.

    Google Scholar 

  4. Shi X, Zhang X, Yi C, Liu Y, He Q. [13N]Ammonia positron emission tomographic/computed tomographic imaging targeting glutamine synthetase expression in prostate cancer. Mol Imaging. 2014;13:1–10.

    Google Scholar 

  5. Lockwood AH. Absorbed doses of radiation after an intravenous injection of N-13 ammonia in man: concise communication. J Nucl Med. 1980;21:276–8.

    CAS  PubMed  Google Scholar 

  6. Stabin MG. Radiopharmaceuticals for nuclear cardiology: radiation dosimetry, uncertainties, and risk. J Nucl Med. 2008;49:1555–63.

    Article  CAS  PubMed  Google Scholar 

  7. Krasikova RN, Fedorova OS, Korsakov MV, Bennington BI, Berridge MS. Improved [N-13]ammonia yield from the proton irradiation of water using methane gas. Appl Radiat Isot. 1999;51:395–401.

    Article  CAS  Google Scholar 

  8. Sgouros G. Dosimetry of internal emitters. J Nucl Med. 2005;46:18S–27S.

    PubMed  Google Scholar 

  9. Cropley VL, Fujita M, Musachio JL, Hong J, Ghose S, Sangare J, et al. Whole-body biodistribution and estimation of radiation-absorbed doses of the dopamine D1 receptor radioligand 11C-NNC 112 in humans. J Nucl Med. 2006;47:100–4.

    CAS  PubMed  Google Scholar 

  10. Mejia AA, Nakamura T, Masatoshi I, Hatazawa J, Masaki M, Watanuki S. Estimation of absorbed doses in human due to intravenous administration of fluorine-18-fluorodeoxyglucose in PET studies. J Nucl Med. 1991;32:699–709.

    CAS  PubMed  Google Scholar 

  11. Seltzer MA, Jahan SA, Sparks R, Stout DB, Satyamurthy N, Dahlbom M, et al. Radiation dose estimates in humans for C-11-acetate whole-body PET. J Nucl Med. 2004;45:1233–6.

    CAS  PubMed  Google Scholar 

  12. Huang T, Wang H, Tang G, Liang X, Deng H, Yi C, et al. Human radiation dose estimation of 11C-CFT using whole-body PET. Clin Nucl Med. 2012;37:1159–62.

    Article  PubMed  Google Scholar 

  13. Cristy M, Eckerman KF. Specific absorbed fractions of energy at various ages from internal photon sources. Oak Ridge: Oak Ridge National Laboratory; 1987.

    Google Scholar 

  14. Tang G, Wang M, Tang X, Luo L, Gan M. Pharmacokinetics and radiation dosimetry estimation of O-(2-[18F]fluoroethyl)-l-tyrosine as oncologic PET tracer. Appl Radiat Isot. 2003;58(2):219–25.

    Article  CAS  PubMed  Google Scholar 

  15. Coffey JL, Watson EE. Calculation dose from remaining body activity: a comparison of two methods. Med Phys. 1979;6:307–8.

    Article  CAS  PubMed  Google Scholar 

  16. International Commission on Radiological Protection. ICRP Publication 60: 1990 Recommendations of the International Commission on Radiological Protection. Oxford: Pergamon; 1991.

    Google Scholar 

  17. Keiding S, Sørensen M, Bender D, Munk OL, Ott P, Vilstrup H. Brain metabolism of 13N-ammonia during acute hepatic encephalopathy in cirrhosis measured by positron emission tomography. Hepatology. 2006;43:42–50.

    Article  CAS  PubMed  Google Scholar 

  18. Cooper AJ. 13N as a tracer for studying glutamate metabolism. Neurochem Int. 2011;59:456–64.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  19. Lockwood AH. Positron emission tomography in the study of hepatic encephalopathy. Metab Brain Dis. 2002;17:431–5.

    Article  CAS  PubMed  Google Scholar 

  20. Lie-Venema H, Hakvoort TB, van Hemert FJ, Moorman AF, Lamers WH. Regulation of the spatiotemporal pattern of expression of the glutamine synthetase gene. Prog Nucleic Acid Res Mol Biol. 1998;61:243–308.

    Article  CAS  PubMed  Google Scholar 

  21. Eisenberg D, Almassy RJ, Janson CA, Chapman MS, Suh SW, Cascio D, et al. Some evolutionary relationships of the primary biological catalysts glutamine synthetase and RuBisCO. Cold Spring Harb Symp Quant Biol. 1987;52:483–90.

    Article  CAS  PubMed  Google Scholar 

  22. Krajewski WW, Collins R, Holmberg-Schiavone L, Jones TA, Karlberg T, Mowbray SL. Crystal structures of mammalian glutamine synthetases illustrate substrate-induced conformational changes and provide opportunities for drug and herbicide design. J Mol Biol. 2008;375:317–28.

    Article  Google Scholar 

  23. Lockwood AH, McDonald JM, Reiman RE, Gelbard AS, Laughlin JS, Duffy TE, et al. The dynamics of ammonia metabolism in man. Effects of liver disease and hyperammonemia. J Clin Invest. 1979;63:449–60.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  24. International Commission on Radiological Protection. ICRP publication 103: The 2007 Recommendations of the International Commission on Radiological Protection. Oxford: Pergamon; 2007.

    Google Scholar 

  25. CFR-Code of Federal Regulations Title 21, part 361. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=361&showFR=1.

Download references

Acknowledgments

The authors wish to thank Professor Ganghua Tang who provided the generous gift of a copy of the S value tables. This study was supported by the 973 program No. 2015CB755500 and the National Natural Science Foundation of China (81271599).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xiangsong Zhang.

Ethics declarations

Conflict of interest

No potential conflicts of interest were disclosed.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yi, C., Yu, D., Shi, X. et al. Biodistribution and estimation of radiation-absorbed doses in humans for 13N-ammonia PET. Ann Nucl Med 29, 810–815 (2015). https://doi.org/10.1007/s12149-015-1012-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12149-015-1012-4

Keywords

Navigation